CGEB, as the lead partner of the Interreg Italy–Slovenia COHERENCE project, announces the launch of a digital platform designed to support researchers and clinicians in achieving regulatory compliance for cell-based Advanced Therapy Medicinal Products (ATMPs).
The web platform is available in three languages (Italian, Slovenian, and English). It provides a clear overview of national (Italian and Slovenian) and European regulations, offers templates and checklists for the required documentation in both countries (including a guide to CTIS), as well as experimental protocols, publications, and conferences.
The platform has been conceived as an open, modular, and scalable tool, aiming to accelerate the transition from preclinical to clinical phases in a safe and ethical manner, while enabling the easy integration of regulatory updatesand new content.
The platform will remain open and continuously expanded to encourage the participation of additional research groups across Europe, thereby broadening its impact and promoting the sharing of best practices in this field.
https://coherenceinterreg.altervista.org/en/the-project-2/
